{
    "id": "5740223",
    "text": "is a Japanese pharmaceutical company based in Tokyo. ==History== Taisho was established in 1912 as Taisho Seiyakusho to produce over-the-counter drugs. In 1928 the company changed its name to Taisho Pharmaceutical Co., Ltd. and in 1955 moved into prescription drug R&D.; It introduced its over-the-counter medications like cough suppressant in 1927, pain reliever in 1967 and an antiulcer agent in 1984. ==Products== The company's principal line of business is over-the-counter (OTC) medicines, where it markets the brands Lipovitan-D, Pabron, Colac, Contac, Tempra, UPSA, Vicks and Kampo In prescription pharmaceuticals, the company's most successful product to date has been the macrolide antibiotic clarithromycin. The company's branded version of the drug, Clarith, was launched in Japan in 1991. For clarithromycin distribution outside Japan Taisho licensed clarithromycin to Abbott Laboratories. ==Ownership== Taisho Pharmaceutical's stock is traded on the Tokyo Stock Exchange and the principal owners of the firm are the Uehara family name. ==Sponsorships== Taisho has sponsored the Japan national rugby union team since 2001. The company is also an Official Sponsor of the Rugby World Cup 2019, which will take place in Japan. ==References== ==External links== * Taisho Pharmaceutical Co., Ltd. Category:Pharmaceutical companies of Japan Category:Pharmaceutical companies based in Tokyo Category:Companies listed on the Tokyo Stock Exchange Category:Pharmaceutical companies established in 1912 Category:Japanese companies established in 1912 Category:Japanese brands ",
    "title": "Taisho Pharmaceutical"
}